Sun Pharma to acquire Innovcare Lifesciences for $28.7m

Sun Pharmaceutical Industries has agreed to acquisition India-based Innovcare Lifesciences successful a woody valued astatine astir Rs2.71bn ($28.7m).

According to a regulatory filing, Sun Pharma volition bargain the full issued and outstanding stock superior of Innovcare Lifesciences via a currency transaction. The institution expects to adjacent the acquisition connected oregon earlier 31 July 2026.

Innovcare Lifesciences operates crossed the Indian market, focusing connected the marketing, distribution, and merchantability of pharmaceutical products, nutraceuticals, and cosmeceuticals.

The institution reported operational gross of Rs940m for the fiscal twelvemonth ending March 2026, pursuing gross of Rs860m successful FY24-FY25 and Rs809m successful FY23-FY24.

Sun Pharma indicated that the planned acquisition is portion of its efforts to grow and fortify its merchandise portfolio.

The institution specified that the transaction is not a related-party arrangement, and neither its promoters nor entities successful the promoter radical person immoderate shareholding oregon involvement successful Innovcare Lifesciences.

Sun Pharma besides stated that nary governmental oregon regulatory approvals are needed to implicit this transaction.

Following the decision of the deal, Sun Pharma volition get afloat ownership and power of Innovcare Lifesciences.

In April 2026, Sun Pharmaceutical Industries agreed to get Organon successful a woody with an endeavor valuation of $11.75bn successful cash, paying $14 per stock for each outstanding shares.

Created done a spinoff from Merck & Co (MSD) successful 2021, Organon distributes much than 70 products crossed women's wellness and wide medicines, including biosimilars, reaching 140 countries.

In March 2026, the US Food and Drug Administration accepted for reappraisal Sun Pharmaceutical's supplemental biologics licence exertion (sBLA) submitted for Ilumya (tildrakizumab-asmn) to dainty adults with progressive psoriatic arthritis.

"Sun Pharma to get Innovcare Lifesciences for $28.7m" was primitively created and published by Pharmaceutical Technology, a GlobalData owned brand.